American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.
作者信息
Hanson Brian, Siddique Shazia Mehmood, Scarlett Yolanda, Sultan Shahnaz
机构信息
Division of Gastroenterology and Hepatology, University of Minnesota and Minneapolis Veterans Affairs Healthcare System, Minneapolis, Minnesota.
Division of Gastroenterology and Liver Disease, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Gastroenterology. 2019 Jan;156(1):229-253.e5. doi: 10.1053/j.gastro.2018.08.018. Epub 2018 Oct 16.
Abstract
摘要
相似文献
1
American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.美国胃肠病学会关于阿片类药物所致便秘药物治疗的技术审查
Gastroenterology. 2019 Jan;156(1):229-253.e5. doi: 10.1053/j.gastro.2018.08.018. Epub 2018 Oct 16.
2
American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation.美国胃肠病学会关于阿片类药物所致便秘药物治疗的指南
Gastroenterology. 2019 Jan;156(1):218-226. doi: 10.1053/j.gastro.2018.07.016. Epub 2018 Oct 16.
3
Opioid-Induced Constipation (OIC) Guideline.阿片类药物所致便秘（OIC）指南。
Gastroenterology. 2019 Jan;156(1):228. doi: 10.1053/j.gastro.2018.10.044. Epub 2018 Oct 30.
4
Opioid-lnduced Constipation (OIC) Clinical Decision Support Tool.阿片类药物所致便秘（OIC）临床决策支持工具
Gastroenterology. 2019 Jan;156(1):227. doi: 10.1053/j.gastro.2018.10.043. Epub 2018 Oct 30.
5
Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.甲基纳曲酮用于治疗危重症儿童便秘
J Clin Gastroenterol. 2016 Apr;50(4):351-2. doi: 10.1097/MCG.0000000000000483.
6
Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.阿片类药物引起的便秘的药物治疗是有效的，但终点的选择会影响治疗效果。
Dig Dis Sci. 2019 Jan;64(1):39-49. doi: 10.1007/s10620-018-5308-9. Epub 2018 Oct 3.
7
Naldemedine effective in treating opioid-induced constipation.纳地美定治疗阿片类药物引起的便秘有效。
Lancet Oncol. 2017 Jun;18(6):e306. doi: 10.1016/S1470-2045(17)30320-0. Epub 2017 May 5.
8
Naldemedine (Symproic) for opioid-induced constipation.纳地美定（Symproic）用于治疗阿片类药物引起的便秘。
Med Lett Drugs Ther. 2017 Dec 4;59(1535):196-198.
9
Emerging therapies for opioid-induced constipation: what can we expect?阿片类药物引起的便秘的新兴治疗方法：我们能期待什么？
Expert Opin Pharmacother. 2024 Sep;25(13):1729-1738. doi: 10.1080/14656566.2024.2407013. Epub 2024 Sep 23.
10
Opioid-induced constipation.阿片类药物引起的便秘。
J Pain Palliat Care Pharmacother. 2012 Dec;26(4):382-4. doi: 10.3109/15360288.2012.734907.
引用本文的文献
1
Konjac Oligosaccharide Alleviates Constipation in Mice via 5-HT4R/cAMP/PKA/p-CREB Pathway Activation.魔芋低聚糖通过激活5-HT4R/cAMP/PKA/p-CREB通路缓解小鼠便秘。
Curr Med Sci. 2025 Aug 29. doi: 10.1007/s11596-025-00102-7.
2
Progresses in Questing for the Truth of Opioid-Related Constipation in Cancer Patients.探索癌症患者阿片类药物相关性便秘真相的进展
J Cell Mol Med. 2025 Apr;29(8):e70553. doi: 10.1111/jcmm.70553.
3
Effects of Functional Red Pine Seed Direct-Drinking Oil on Constipation and Intestinal Barrier Function in Mice.功能性红松籽直饮油对小鼠便秘及肠道屏障功能的影响
Antioxidants (Basel). 2024 Dec 25;14(1):14. doi: 10.3390/antiox14010014.
4
Traditional laxatives in preventing opioid-induced constipation in adult patients with cancer: a systematic review and meta-analysis protocol.传统泻药预防成年癌症患者阿片类药物所致便秘的系统评价和Meta分析方案
BMJ Open. 2024 Dec 26;14(12):e086001. doi: 10.1136/bmjopen-2024-086001.
5
The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study.在真实世界的姑息治疗环境中，纳洛肽用于治疗晚期癌症患者阿片类药物引起的便秘的安全性和有效性：一项多中心前瞻性观察研究。
Support Care Cancer. 2024 Jul 10;32(8):504. doi: 10.1007/s00520-024-08716-8.
6
Regulation of enteric nervous system via sacral nerve stimulation in opioid-induced constipated rats.骶神经刺激对阿片类药物诱导便秘大鼠肠道神经系统的调节作用
Front Neurosci. 2023 Jun 2;17:1146883. doi: 10.3389/fnins.2023.1146883. eCollection 2023.
7
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.与癌症患者中纳洛酮治疗阿片类药物引起的便秘无应答相关的因素：亚组分析。
PLoS One. 2022 Dec 9;17(12):e0278823. doi: 10.1371/journal.pone.0278823. eCollection 2022.
8
Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation.异常胆汁酸代谢是慢传输型便秘患者肠道微生物群和粪便代谢物的一个重要特征。
Front Cell Infect Microbiol. 2022 Jul 28;12:956528. doi: 10.3389/fcimb.2022.956528. eCollection 2022.
9
TY-S01 Prevents Loperamide-Induced Constipation by Modulating Gut Microbiota and Its Metabolites in Mice.TY-S01通过调节小鼠肠道微生物群及其代谢产物预防洛哌丁胺诱导的便秘。
Front Nutr. 2022 Jun 29;9:890314. doi: 10.3389/fnut.2022.890314. eCollection 2022.
10
Effects of Maren Pills on the Intestinal Microflora and Short-Chain Fatty Acid Profile in Drug-Induced Slow Transit Constipation Model Rats.麻仁丸对药物诱导的慢传输型便秘模型大鼠肠道菌群及短链脂肪酸谱的影响
Front Pharmacol. 2022 Apr 12;13:804723. doi: 10.3389/fphar.2022.804723. eCollection 2022.
本文引用的文献
1
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.阿片类药物引起的便秘的药物治疗疗效：系统评价和网络荟萃分析。
Gut. 2019 Mar;68(3):434-444. doi: 10.1136/gutjnl-2018-316001. Epub 2018 May 5.
2
Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.长期使用纳洛美丁治疗慢性非癌痛患者阿片类药物引起的便秘：一项随机、双盲、安慰剂对照的 3 期研究。
Pain. 2018 May;159(5):987-994. doi: 10.1097/j.pain.0000000000001174.
3
Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.阿片类药物引起的便秘的治疗效果：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1569-1584.e2. doi: 10.1016/j.cgh.2018.01.021. Epub 2018 Jan 31.
4
Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.鲁比前列酮治疗阿片类药物诱导性便秘的疗效和安全性：3 期研究结果及合并使用美沙酮对临床结局影响的汇总分析。
Pain Med. 2018 Jun 1;19(6):1184-1194. doi: 10.1093/pm/pnx156.
5
Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer.纳洛美丁治疗阿片类药物引起的便秘和癌症患者的随机 III 期和扩展研究。
J Clin Oncol. 2017 Dec 1;35(34):3859-3866. doi: 10.1200/JCO.2017.73.0853. Epub 2017 Oct 2.
6
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.美国成年人的处方阿片类药物使用、滥用和使用障碍：2015 年全国毒品使用与健康调查。
Ann Intern Med. 2017 Sep 5;167(5):293-301. doi: 10.7326/M17-0865. Epub 2017 Aug 1.
7
8
Prevalence and clinical features of opioid-induced constipation in the general population: A French study of 15,000 individuals.普通人群中阿片类药物所致便秘的患病率及临床特征：一项针对15000人的法国研究
United European Gastroenterol J. 2017 Jun;5(4):588-600. doi: 10.1177/2050640616659967. Epub 2016 Jul 7.
9
Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.纳洛美丁与安慰剂治疗阿片类药物引起的便秘（COMPOSE-1 和 COMPOSE-2）：两项多中心、3 期、双盲、随机、平行组试验。
Lancet Gastroenterol Hepatol. 2017 Aug;2(8):555-564. doi: 10.1016/S2468-1253(17)30105-X. Epub 2017 May 30.
10
The GRADE Working Group clarifies the construct of certainty of evidence.GRADE工作组对证据确定性的概念进行了澄清。
J Clin Epidemiol. 2017 Jul;87:4-13. doi: 10.1016/j.jclinepi.2017.05.006. Epub 2017 May 18.
Zotero 插件